On April 21, 2026, Bio-Rad Laboratories' stockholders approved an Amended Incentive Award Plan, increasing shares reserved by 335,000 and extending its term to March 18, 2036. The meeting also saw the election of directors and ratification of auditors, reflecting positive investor engagement.